Substituted 1,8-naphthyridinecarboxamides for use as prolyl hydroxylase inhibitors
申请人:Glaxosmithkline, LLC
公开号:US07897612B2
公开(公告)日:2011-03-01
The invention described herein relates to certain bicyclic heteroaromatic N-substituted glycine derivatives of formula (I)
which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
The invention described herein relates to certain bicyclic heteroaromatic N-substituted glycine derivatives of formula (I)
which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.